Kaufman, J., J. Cohen, M. Peredo, B. Jonas, A. Nogueira, and J. H. Mashburn. “Two On-Label Injection Volumes of AbobotulinumtoxinA (ABO) Produce Simlar Safety and Efficacy Results When Used to Treate Moderate to Sever Glabellar Lines”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s91, doi:10.25251/skin.1.supp.90.